Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.
L C Madoff, … , J Y Tai, D L Kasper
L C Madoff, … , J Y Tai, D L Kasper
Published July 1, 1994
Citation Information: J Clin Invest. 1994;94(1):286-292. https://doi.org/10.1172/JCI117319.
View: Text | PDF
Research Article Article has an altmetric score of 9

Maternal immunization of mice with group B streptococcal type III polysaccharide-beta C protein conjugate elicits protective antibody to multiple serotypes.

  • Text
  • PDF
Abstract

Group B streptococcal infection is a major cause of neonatal mortality. Antibody to the capsular polysaccharide protects against invasive neonatal disease, but immunization with capsular polysaccharides fails to elicit protective antibody in many recipients. Conjugation of the polysaccharide to tetanus toxoid has been shown to increase immune response to the polysaccharide. In animal models, C proteins of group B streptococci are also protective determinants. We examined the ability of the beta C protein to serve in the dual role of carrier for the polysaccharide and protective immunogen. Type III polysaccharide was covalently coupled to beta C protein by reductive amination. Immunization of rabbits with the polysaccharide-protein conjugate elicited high titers of antibody to both components, and the serum induced opsonophagocytic killing of type III, Ia/C, and Ib/C strains of group B streptococci. Female mice were immunized with the conjugate vaccine and then bred; 93% of neonatal pups born to these dams vaccinated with conjugate survived type III group B streptococcal challenge and 76% survived type Ia/C challenge, compared with 3% and 8% survival, respectively, in controls (P < 0.001). The beta C protein acted as an effective carrier for the type III polysaccharide while simultaneously induced protective immunity against beta C protein--containing strains of group B streptococci.

Authors

L C Madoff, L C Paoletti, J Y Tai, D L Kasper

×

Total citations by year

Year: 2024 2020 2019 2018 2017 2016 2014 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1988 Total
Citations: 1 1 3 1 1 1 2 1 1 1 1 2 1 4 5 1 3 6 6 3 5 5 2 7 2 1 67
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (67)

Title and authors Publication Year
Using Surface Immunogenic Protein as a Carrier Protein to Elicit Protective Antibody to Multiple Serotypes for Candidate Group B Streptococcal Glycan Conjugate Vaccines
Duan H, Huang W, Lv Q, Liu P, Li Q, Kong D, Sun X, Zhang X, Jiang Y, Chen S
Human vaccines 2024
Vaccines for Perinatal and Congenital Infections—How Close Are We?
T Singh, CE Otero, K Li, SM Valencia, AN Nelson, SR Permar
Frontiers in Pediatrics 2020
The role of immune correlates of protection on the pathway to licensure, policy decision and use of group B Streptococcus vaccines for maternal immunization: considerations from World Health Organization consultations
J Vekemans, J Crofts, CJ Baker, D Goldblatt, PT Heath, SA Madhi, KL Doare, N Andrews, AJ Pollard, SK Saha, SJ Schrag, PG Smith, DC Kaslow
Vaccine 2019
Gram-Positive Pathogens
VA Fischetti, RP Novick, JJ Ferretti, DA Portnoy, M Braunstein, JI Rood
2019
Surface Structures of Group B Streptococcus Important in Human Immunity
LC Paoletti, DL Kasper, VA Fischetti, RP Novick, JJ Ferretti, DA Portnoy, M Braunstein, JI Rood
Microbiology spectrum 2019
Streptococcus agalactiae Non-Pilus, Cell Wall-Anchored Proteins: Involvement in Colonization and Pathogenesis and Potential as Vaccine Candidates
G Pietrocola, CR Arciola, S Rindi, L Montanaro, P Speziale
Frontiers in immunology 2018
Association between antibodies against group B Streptococcus surface proteins and recto-vaginal colonisation during pregnancy
S Dzanibe, G Kwatra, PV Adrian, SZ Kimaro-Mlacha, CL Cutland, SA Madhi
Scientific Reports 2017
Group B Streptococcus vaccine development: present status and future considerations, with emphasis on perspectives for low and middle income countries
M Kobayashi, J Vekemans, CJ Baker, AJ Ratner, KL Doare, SJ Schrag
F1000Research 2016
Maternal vaccination: moving the science forward
AN Faucette, BL Unger, B Gonik, K Chen
Human Reproduction Update 2014
Current Status of Vaccine Development for Group B Streptococcus
KM Puopolo
NeoReviews 2014
Fine specificity and cross-reactions of monoclonal antibodies to group B streptococcal capsular polysaccharide type III
SH Pincus, E Moran, G Maresh, HJ Jennings, DG Pritchard, ML Egan, O Blixt
Vaccine 2012
Infectious Diseases of the Fetus and Newborn
V Nizet, JS Bradley
Infectious Diseases of the Fetus and Newborn 2011
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases
VG Fowler, WM Scheld, AS Bayer
Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases 2010
Streptococcus adherence and colonization
AH Nobbs, RJ Lamont, HF Jenkinson
Microbiology and molecular biology reviews : MMBR 2009
Human pathogenic streptococcal proteomics and vaccine development
JN Cole, A Henningham, CM Gillen, V Ramachandran, MJ Walker
PROTEOMICS – CLINICAL APPLICATIONS 2008
Recombinant Group B Streptococcus Alpha-Like Protein 3 Is an Effective Immunogen and Carrier Protein
HH Yang, SJ Mascuch, LC Madoff, LC Paoletti
Clinical and vaccine immunology : CVI 2008
Recombinant Group B Streptococcus Beta C Protein and a Variant with the Deletion of Its Immunoglobulin A-Binding Site Are Protective Mouse Maternal Vaccines and Effective Carriers in Conjugate Vaccines
HH Yang, LC Madoff, HK Guttormsen, YD Liu, LC Paoletti
Infection and immunity 2007
Adjacent location of thebac gene and two-component regulatory system genes within the putativeStreptococcus agalactiae pathogenicity island
A Dmitriev, YH Yang, AD Shen, A Totolian
Folia Microbiologica 2006
Group B Streptococcus: global incidence and vaccine development
AK Johri, LC Paoletti, P Glaser, M Dua, PK Sharma, G Grandi, R Rappuoli
Nature Reviews Microbiology 2006
Infectious Diseases of the Fetus and Newborn Infant
RC Orscheln, HR Shinefield, JW st. Geme
Infectious Diseases of the Fetus and Newborn Infant 2006
The Prokaryotes
M Dworkin, S Falkow, E Rosenberg, KH Schleifer, E Stackebrandt
2006
Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens
G Lindahl, M Stålhammar-Carlemalm, T Areschoug
Clinical microbiology reviews 2005
Vaccination against Group B streptococcus
PT Heath, RG Feldman
Expert Review of Vaccines 2005
Group B Streptococcal Colonization and Serotype-Specific Immunity in Healthy Elderly Persons
MS Edwards, MA Rench, DL Palazzi, CJ Baker
Clinical Infectious Diseases 2005
Immunology of the Fetus and Newborn
CB Williams, FS Cole
Avery s Diseases of the Newborn 2005
Mucosal Immunology
WR Brown
Mucosal Immunology 2005
Immunization of female mice with glycoconjugates protects their offspring against encapsulated bacteria
MY Richter, H Jakobsen, A Birgisdottir, JF Haeuw, UF Power, GD Giudice, A Bartoloni, I Jonsdottir
Infection and immunity 2004
Glycoconjugate vaccines to prevent group B streptococcal infections
LC Paoletti, DL Kasper
Expert Opinion on Biological Therapy 2003
Mucosal Vaccination Against Encapsulated Respiratory Bacteria - New Potentials for Conjugate Vaccines?
H Jakobsen, I Jonsdottir
Scandinavian Journal of Immunology 2003
New Bacterial Vaccines
RW Ellis, BR Brodeur
2003
Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein
D Martin, S Rioux, E Gagnon, M Boyer, J Hamel, N Charland, BR Brodeur
Infection and immunity 2002
Immunization with C5a peptidase or peptidase-type III polysaccharide conjugate vaccines enhances clearance of group B Streptococci from lungs of infected mice
Q Cheng, S Debol, H Lam, R Eby, L Edwards, Y Matsuka, SB Olmsted, PP Cleary
Infection and immunity 2002
Polymorphisms in the Cell Wall–Spanning Domain of the C Protein β-Antigen in Clinical Streptococcus agalactiae Isolates Are Caused by Genetic Instability of Repeating DNA Sequences
R Berner, M Ruess, S Bereswill, M Brandis
Pediatric Research 2002
Vaccines to prevent neonatal GBS infection
LC Paoletti, LC Madoff
Seminars in Neonatology 2002
A Proline-Rich Region with a Highly Periodic Sequence in Streptococcal β Protein Adopts the Polyproline II Structure and Is Exposed on the Bacterial Surface
T Areschoug, S Linse, M Stålhammar-Carlemalm, LO Hedén, G Lindahl
Journal of bacteriology 2002
A proline-rich region with a highly periodic sequence in Streptococcal beta protein adopts the polyproline II structure and is exposed on the bacterial surface.
Areschoug T, Linse S, Stålhammar-Carlemalm M, Hedén LO, Lindahl G
Journal of bacteriology 2002
Preclinical evaluation of group B streptococcal polysaccharide conjugate vaccines prepared with a modified diphtheria toxin and a recombinant duck hepatitis B core antigen
LC Paoletti, DL Peterson, R Legmann, RJ Collier
Vaccine 2001
Potency of clinical group B streptococcal conjugate vaccines
LC Paoletti
Vaccine 2001
Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate
X Shen, T Lagergård, Y Yang, M Lindblad, M Fredriksson, G Wallerström, J Holmgren
Vaccine 2001
Vaccines in Pregnancy
FM Munoz, JA Englund
Infectious Disease Clinics of North America 2001
Antibody against Surface-Bound C5a Peptidase Is Opsonic and Initiates Macrophage Killing of Group B Streptococci
EI Tuomanen, Q Cheng, B Carlson, S Pillai, R Eby, L Edwards, SB Olmsted, P Cleary
Infection and immunity 2001
Group B Streptococcus Capsular Polysaccharide-Cholera Toxin B Subunit Conjugate Vaccines Prepared by Different Methods for Intranasal Immunization
EI Tuomanen, X Shen, T Lagergård, Y Yang, M Lindblad, M Fredriksson, J Holmgren
Infection and immunity 2001
Preparation and preclinical evaluation of experimental group B streptococcus type III polysaccharide–cholera toxin B subunit conjugate vaccine for intranasal immunization
X Shen, T Lagergård, Y Yang, M Lindblad, M Fredriksson, J Holmgren
Vaccine 2000
Pathogenesis of neonatal Streptococcusagalactiae infections
B Spellerberg
Microbes and Infection 2000
Persistent Bacterial Infections
JP Nataro, MJ Blaser, S Cunningham-Rundles
2000
AnEscherichia coli-Enterococcus faecalisshuttle vector as a tool for the construction of a group BStreptococcusheterologous mutant expressing the β antigen (Bac) of the C protein complex
B Kreikemeyer, PG Jerlström
FEMS Microbiology Letters 1999
Neonatal group B streptococcal disease in Finland: a ten-year nationwide study
S Kalliola, J Vuopio-Varkila, AK Takala, J Eskola
The Pediatric Infectious Disease Journal 1999
Properties and distribution of the putative R3 protein ofStreptococcus agalactiae
AI Kvam, L Bevanger, JA Maeland
APMIS 1999
Alpha C Protein as a Carrier for Type III Capsular Polysaccharide and as a Protective Protein in Group B Streptococcal Vaccines
VA Fischetti, C Gravekamp, DL Kasper, LC Paoletti, LC Madoff
Infection and immunity 1999
Lmb, a Protein with Similarities to the LraI Adhesin Family, Mediates Attachment of Streptococcus agalactiae to Human Laminin
EI Tuomanen, B Spellerberg, E Rozdzinski, S Martin, J Weber-Heynemann, N Schnitzler, R Lütticken, A Podbielski
Infection and immunity 1999
Capsular polysaccharide-protein conjugate vaccines and intravenous immunoglobulins
RK Sood, A Fattom
Expert Opinion on Investigational Drugs 1998
Cervical Secretions in Pregnant Women Colonized Rectally with Group B Streptococci have High Levels of Antibodies to Serotype III Polysaccharide Capsular Antigen and Protein R
Hordnes, Tynning, Kvam, Bevanger, Brown, Jonsson, Haneberg
Scandinavian Journal of Immunology 1998
Structural properties of group B streptococcal type III polysaccharide conjugate vaccines that influence immunogenicity and efficacy
MR Wessels, LC Paoletti, HK Guttormsen, F Michon, AJ D'Ambra, DL Kasper
Infection and immunity 1998
Vaccines: From Concept to Clinic: A Guide to the Development and Clinical Testing of Vaccines for Human Use
A Onderdonk, R Kennedy
Vaccines: From Concept to Clinic: A Guide to the Development and Clinical Testing of Vaccines for Human Use 1998
Structural Properties of Group B Streptococcal Type III Polysaccharide Conjugate Vaccines That Influence Immunogenicity and Efficacy
MR Wessels, LC Paoletti, HK Guttormsen, F Michon, AJ DAmbra, DL Kasper
Infection and immunity 1998
Prospects for Vaccines During Pregnancy and in the Newborn Period
GW Fischer, MG Ottolini, JJ Mond
Clinics in Perinatology 1997
Streptococci and the Host
T Horaud, A Bouvet, R Leclercq, H de Montclos, M Sicard
1997
Immune responses to infectious diseases: an evolutionary perspective
KD Yang, HR Hill
The Pediatric Infectious Disease Journal 1996
Immunogenicity of group B Streptococcus type III polysaccharide-tetanus toxoid vaccine in baboons
LC Paoletti, RC Kennedy, TC Chanh, DL Kasper
Infection and immunity 1996
Experimental vaccination against group B streptococcus, an encapsulated bacterium, with highly purified preparations of cell surface proteins Rib and alpha
C Larsson, M Stålhammar-Carlemalm, G Lindahl
Infection and immunity 1996
Identification of an immunoglobulin A binding motif located in the beta-antigen of the c protein complex of group B streptococci
PG Jerlström, SR Talay, P Valentin-Weigand, KN Timmis, GS Chhatwal
Infection and immunity 1996
Colonization in the rectum and uterine cervix with group B streptococci may induce specific antibody responses in cervical secretions of pregnant women
K Hordnes, T Tynning, AI Kvam, R Jonsson, B Haneberg
Infection and immunity 1996
Synthesis and NMR assignment of two repeating units (decasaccharide) of the type III group B Streptococcus capsular polysaccharide and its 13C-labeled and N-propionyl substituted sialic acid analogues
W Zou, JR Brisson, QL Yang, M der Zwan, HJ Jennings
Carbohydrate Research 1996
Group B Streptococcus and Pregnancy
BM Mercer, RG Briggs
Pediatric Annals 1996
Capsular polysaccharide-protein conjugate vaccines of carbotype 1 Vibrio vulnificus: construction, immunogenicity, and protective efficacy in a murine model
SJ Devi, U Hayat, CE Frasch, AS Kreger, JG Morris
Infection and immunity 1995
Mucosal immunogenicity of polysaccharides conjugated to a peptide or multiple-antigen peptide containing T- and B-cell epitopes
E Lett, C Klopfenstein, JP Klein, M Schöller, D Wachsmann
Infection and immunity 1995
Group B Streptococcal Infections
CJ Baker, MS Edwards
Annals of the New York Academy of Sciences 1988

← Previous 1 2 3 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 44 patents
18 readers on Mendeley
See more details